Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019
Stock Options [Member]
Antidilutive securities excluded from computation of earnings per share, amount		2,875,000	2,735,000
Warrants [Member]
Antidilutive securities excluded from computation of earnings per share, amount	[1]	1,473,000	58,000
Restricted Stock Units [Member]
Antidilutive securities excluded from computation of earnings per share, amount		37,000	41,000

[1] AgeX issued Juvenescence warrants to purchase 2,638,401 shares of AgeX common stock as consideration for the line of credit under the Loan Agreements discussed in Note 4.